- Home
- NTB vs CLDX Comparison
NTB vs CLDX Comparison
Compare NTB & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NTB | CLDX |
|---|---|---|
| Founded | 1858 | N/A |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.6B |
| IPO Year | 2016 | 1995 |
Fundamental Metrics
Financial Performance| Metric | NTB | CLDX |
|---|---|---|
| Price | $60.20 | $35.60 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 10 |
| Target Price | ★ $53.75 | $46.60 |
| AVG Volume (30 Days) | 127.5K | ★ 1.0M |
| Earning Date | 04-28-2026 | 05-04-2026 |
| Dividend Yield | ★ 3.66% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $12,743,000.00 |
| Revenue This Year | $0.84 | $111.39 |
| Revenue Next Year | $4.16 | $235.85 |
| P/E Ratio | $9.64 | ★ N/A |
| Revenue Growth | N/A | ★ 87.78 |
| 52 Week Low | $40.59 | $19.72 |
| 52 Week High | $62.46 | $40.30 |
Technical Indicators
Market Signals| Indicator | NTB | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 51.69 | 50.06 |
| Support Level | $57.71 | $28.51 |
| Resistance Level | $61.11 | $40.30 |
| Average True Range (ATR) | 1.03 | 1.51 |
| MACD | -0.18 | -0.44 |
| Stochastic Oscillator | 33.13 | 35.29 |
Price Performance
Historical ComparisonAbout NTB Bank of N.T. Butterfield & Son Limited (The) Voting
Bank of N.T Butterfield & Son Ltd is a full-service bank and wealth manager. It offers banking services, comprising retail and corporate banking, and wealth management services, which consist of trust, private banking, and asset management business. The company operates through four reportable segments: Bermuda, Cayman, Channel Islands and the UK, and Other. In its Bermuda and Cayman segments, the company offers retail banking and wealth management services. In the Channel Islands and the UK segment, the company offers retail and corporate banking and wealth management services, and the Other segment includes its operations in the Bahamas, Canada, Mauritius, Singapore, and Switzerland. Maximum revenue for the company is generated from its business in Bermuda.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.